Literature DB >> 10063674

Measles eradication: experience in the Americas.

C A de Quadros1, B S Hersh, A C Nogueira, P A Carrasco, C M da Silveira.   

Abstract

In 1994, the Ministers of Health from the Region of the Americas targeted measles for eradication from the Western Hemisphere by the year 2000. To achieve this goal, the Pan American Health Organization (PAHO) developed an enhanced measles eradication strategy. First, a one-time-only "catch-up" measles vaccination campaign is conducted among children aged 9 months to 14 years. Efforts are then made to vaccinate through routine health services ("keep-up") at least 95% of each newborn cohort at 12 months of age. Finally, to assure high population immunity among preschool-aged children, indiscriminate "follow-up" measles vaccination campaigns are conducted approximately every 4 years. These vaccination activities are accompanied by improvements in measles surveillance, including the laboratory testing of suspected measles cases. The implementation of the PAHO strategy has resulted in a marked reduction in measles incidence in all countries of the Americas. Indeed, in 1996 the all-time regional record low of 2109 measles cases was reported. There was a relative resurgence of measles in 1997 with over 20,000 cases, due to a large measles outbreak among infants, preschool-aged children and young adults in São Paulo, Brazil. Contributing factors for this outbreak included: low routine infant vaccination coverage, failure to conduct a "follow-up" campaign, presence of susceptible young adults, and the importation of measles virus, apparently from Europe. PAHO's strategy has been effective in interrupting measles virus circulation. This experience demonstrates that global measles eradication is an achievable goal using currently available measles vaccines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10063674      PMCID: PMC2305693     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

1.  The epidemiology of measles.

Authors:  C J Clements; M Strassburg; F T Cutts; C Torel
Journal:  World Health Stat Q       Date:  1992

2.  Studies with a further attenuated live measles-virus vaccine.

Authors:  S KRUGMAN; J P GILES; A M JACOBS; H FRIEDMAN
Journal:  Pediatrics       Date:  1963-06       Impact factor: 7.124

3.  Update on elimination of measles in the Caribbean.

Authors:  C J Hospedales
Journal:  West Indian Med J       Date:  1992-03       Impact factor: 0.171

4.  Measles--United States, 1996, and the interruption of indigenous transmission.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-03-21       Impact factor: 17.586

5.  Measles in developing countries. Part I. Epidemiological parameters and patterns.

Authors:  A R McLean; R M Anderson
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

Review 6.  Measles elimination in the Americas. Evolving strategies.

Authors:  C A de Quadros; J M Olivé; B S Hersh; M A Strassburg; D A Henderson; D Brandling-Bennett; G A Alleyne
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

7.  Measles in England and Wales--I: An analysis of factors underlying seasonal patterns.

Authors:  P E Fine; J A Clarkson
Journal:  Int J Epidemiol       Date:  1982-03       Impact factor: 7.196

  7 in total
  6 in total

1.  When is a disease eradicable? 100 years of lessons learned.

Authors:  B Aylward; K A Hennessey; N Zagaria; J M Olivé; S Cochi
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

Review 2.  Post-infectious encephalomyelitis.

Authors:  Cornelia Mihai; Burk Jubelt
Journal:  Curr Neurol Neurosci Rep       Date:  2005-11       Impact factor: 6.030

3.  Correlation between measles vaccine doses: implications for the maintenance of elimination.

Authors:  A McKee; M J Ferrari; K Shea
Journal:  Epidemiol Infect       Date:  2018-02-21       Impact factor: 4.434

4.  Waiting time to infectious disease emergence.

Authors:  Christopher J Dibble; Eamon B O'Dea; Andrew W Park; John M Drake
Journal:  J R Soc Interface       Date:  2016-10       Impact factor: 4.118

5.  Vaccination strategies for measles control and elimination: time to strengthen local initiatives.

Authors:  F T Cutts; M J Ferrari; L K Krause; A J Tatem; J F Mosser
Journal:  BMC Med       Date:  2021-01-05       Impact factor: 8.775

Review 6.  Measles Elimination Activities in the Western Pacific Region: Experience from the Republic of Korea.

Authors:  Young June Choe; Youngmee Jee; Myoung-don Oh; Jong-Koo Lee
Journal:  J Korean Med Sci       Date:  2015-11-06       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.